what is the main difference between semaglutide and tirzepatide vs πβοΈ Both are powerful medications for diabetes weight loss, but tirzepatide's dual GIP + GLP-1 action may lead to even greater weight loss and glucose control. Semaglutide offers When it comes to the
Description
The conservative shelf life for reconstituted peptide is 28 days, though some protocols document stability up to 60 days when stored properly
Both tirzepatide and semaglutide are well-characterised in type 2 diabetes research models, with extensive phase 3 trial data supporting their use in glycaemic endpoint studies

the provider does not need to be Medicare-enrolled) Receive prior authorization from your Part D plan, which is the standard pre-approval process Medicare uses for covered medications Patients who initiated GLP-1 therapy before the Bridge Program launched can still qualify if they met the BMI criteria at the time therapy was initiated, even if their current BMI is now lower (a common situation for patients who have already achieved meaningful weight loss)

Essentially, Hims & Hers has found success because it has been able to sell semaglutide, but only because there is a shortage